Effect of nano-formulated Panitumumab on AKT/PTEN/caspase 3 apoptosis and gene expression and BAX/Bcl2 signaling pathway in KRAS-mutant SW480 cells
- 16 June 2025
- journal article
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
- Vol. 47 (3) , 274-286
Abstract
Background. This study aims to design and synthesize a nanostructure to address drug resistance in colorectal cancer cells. Specifically, it targets cells with mutations in the KRAS gene that resist the chemotherapy drug, Panitumumab. Then, the biological effects of this nanostructure were investigated in colorectal cancer cells (SW480). Methods. The targeted nanostructure was composed of PEGylated gold nanoparticles conjugated to Panitumumab (GNP-PEG-Pan), and its physicochemical properties were determined. The cytotoxic effects of this nanostructure on SW480 cells were assessed using the MTT assay technique. The effect of this nanostructure on apoptosis in cancer cells was evaluated using flow cytometry techniques. The expression levels of genes involved in apoptosis, including AKT, PTEN, Bax, Bcl2, and Caspase 3, were evaluated after the application of the targeted nanostructure using Real-time PCR techniques. Results. The results of the study indicated cytotoxic and apoptotic effects of the targeted nanostructure against SW480 cells and overcoming drug resistance in this cell line. This targeted nanostructure played a key role in inducing apoptosis in KRAS mutant colorectal cancer cells by increasing the expression of PTEN, Bax, and caspase 3 genes and decreasing the expression of the AKT and Bcl2 genes. Conclusion. Our findings demonstrated that the engineered nanostructure can inhibit cell proliferation and induce apoptosis in KRAS mutant colorectal cancer cells. Therefore, this nano-formulated antibody can be proposed as a novel therapeutic option for colorectal cancer and other solid tumors. Practical Implications. The engineered targeted nanostructure (GNP-PEG-Pan) enhances cytotoxic effects and induces apoptosis in KRAS-mutant CRC cells resistant to Panitumumab.Keywords
This publication has 28 references indexed in Scilit:
- Apoptosis and its pathways as targets for intracellular pathogens to persist in cellsParasitology Research, 2023
- Eradication of KRAS mutant colorectal adenocarcinoma by PEGylated gold nanoparticles-cetuximab conjugates through ROS-dependent apoptosisColloids and Surfaces A: Physicochemical and Engineering Aspects, 2022
- Caspase-mediated regulation of the distinct signaling pathways and mechanisms in neuronal survivalInternational Immunopharmacology, 2022
- Bio-nano scale modifications of melittin for improving therapeutic efficacyExpert Opinion on Biological Therapy, 2022
- Caspase‐3 regulates the migration, invasion and metastasis of colon cancer cellsInternational Journal of Cancer, 2018
- Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticlesScientific Reports, 2014
- XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsBritish Journal of Cancer, 2011
- Flow Cytometry-Based Apoptosis Detection2009
- Impact of EGFR expression on colorectal cancer patient prognosis and survivalAnnals of Oncology, 2005
- Monoclonal antibodies to target epidermal growth factor receptor–positive tumorsCancer, 2002